Ameriprise
DOCS icon

Ameriprise’s Doximity DOCS Stock Holding History

Ameriprise’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Sell
110,773
-533,506
-83% -$11.8M ﹤0.01% 3003
2026
Q1 		$15M Buy
644,279
+205,628
+47% +$6.41M ﹤0.01% 1614
2025
Q4 		$19.4M Sell
438,651
-221,450
-34% -$12.4M ﹤0.01% 1436
2025
Q3 		$48.3M Buy
660,101
+416,219
+171% +$27.1M 0.01% 901
2025
Q2 		$15M Sell
243,882
-127,406
-34% -$7.11M ﹤0.01% 1525
2025
Q1 		$21.5M Buy
371,288
+65,614
+21% +$4.14M 0.01% 1263
2024
Q4 		$16.3M Sell
305,674
-4,934
-2% -$242K ﹤0.01% 1473
2024
Q3 		$13.5M Buy
310,608
+174,705
+129% +$5.83M ﹤0.01% 1565
2024
Q2 		$3.8M Sell
135,903
-422
-0.3% -$11.1K ﹤0.01% 2497
2024
Q1 		$3.67M Buy
136,325
+1,570
+1% +$44.8K ﹤0.01% 2553
2023
Q4 		$3.78M Sell
134,755
-1,030,705
-88% -$24.3M ﹤0.01% 2544
2023
Q3 		$24.7M Sell
1,165,460
-575,816
-33% -$15.7M 0.01% 1089
2023
Q2 		$59.2M Buy
1,741,276
+429,523
+33% +$14.3M 0.02% 690
2023
Q1 		$42.5M Sell
1,311,753
-961,437
-42% -$31.9M 0.01% 831
2022
Q4 		$76.3M Sell
2,273,190
-3,060,853
-57% -$93.5M 0.03% 563
2022
Q3 		$161M Sell
5,334,043
-673,243
-11% -$24.7M 0.06% 331
2022
Q2 		$209M Buy
6,007,286
+309,562
+5% +$12.2M 0.07% 287
2022
Q1 		$297M Buy
5,697,724
+1,540,370
+37% +$77.5M 0.09% 246
2021
Q4 		$208M Buy
4,157,354
+2,501,261
+151% +$163M 0.06% 345
2021
Q3 		$134M Buy
1,656,093
+414,842
+33% +$30.3M 0.04% 429
2021
Q2 		$72.3M Buy
+1,241,251
New +$69.7M 0.02% 639

Other funds holding DOCS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ameriprise's DOCS Position: Q2 2026 in Review

Ameriprise reduced its Doximity (DOCS) stake by 83% in Q2 2026, selling an estimated $11.8M and leaving 110,773 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Ameriprise first reported a position in DOCS in Q2 2021 and has held it in 21 quarters since. The position peaked at $297M in Q1 2022. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Ameriprise held 110,773 shares of Doximity worth $2.3M as of Q2 2026.
  • Ameriprise sold 533,506 Doximity shares in Q2 2026, an estimated $11.8M.
  • Doximity made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3003 holding.
  • Ameriprise first reported a position in Doximity in Q2 2021 and has held it in 21 quarters since.
  • Ameriprise's Doximity position peaked at $297M in Q1 2022.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.